Patient Safety Organizations: Voluntary Relinquishment From Medical Peer Review Resource, LLC, 25866-25867 [2014-10279]
Download as PDF
<![CDATA[
25866
Federal Register / Vol. 79, No. 87 / Tuesday, May 6, 2014 / Notices
Oostdyk, both of Plymouth, Minnesota;
Justin Gabrielse, Maple Grove,
Minnesota; Jayne Locascio, Palos Park,
Illinois; William Oostdyk, South Elgin,
Illinois; Valerie Therrien, Minneapolis,
Minnesota; Katie Nelson, Frostburg,
Maryland; and Keith Gabrielse, Cottage
Grove, Wisconsin; together as a group
acting in concert, to retain voting shares
of Oak Financial, Inc., and thereby
indirectly retain voting shares of Oak
Bank, both in Fitchburg, Wisconsin.
B. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Tommy D. Craighead, Norman,
Oklahoma, as trustee of the TCC & BJC
Trusts No. 1 through 7, Ardmore,
Oklahoma; to acquire voting shares of
Citizens Commerce Corporation, and
thereby indirectly acquire voting shares
of Citizens Bank & Trust Company of
Ardmore, both in Ardmore, Oklahoma.
Board of Governors of the Federal Reserve
System, May 1, 2014.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2014–10323 Filed 5–5–14; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
In accordance with section 10
(a) (2) of the Federal Advisory
Committee Act (5 U.S.C. App. 2),
announcement is made of an Agency for
Healthcare Research and Quality
(AHRQ) Special Emphasis Panel (SEP)
meeting on ‘‘AHRQ RFA–HS14–005,
Patient Safety Learning Laboratories;
Applying Design Innovation and
Systems Engineering (P30)’’. Each SEP
meeting will commence in open session
before closing to the public for the
duration of the meeting.
DATES: May 29, 2014 (Open on May 29
from 8:00 a.m. to 8:30 a.m. and closed
for the remainder of the meeting).
ADDRESSES: Gaithersburg Marriott
Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg,
Maryland 20878.
FOR FURTHER INFORMATION CONTACT:
Anyone wishing to obtain a roster of
members, agenda or minutes of the nonconfidential portions of this meeting
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:34 May 05, 2014
Jkt 232001
should contact: Mrs. Bonnie Campbell,
Committee Management Officer, Office
of Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone: (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the Agency for
Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Each SEP meeting will commence in
open session before closing to the public
for the duration of the meeting. The SEP
meeting referenced above will be closed
to the public in accordance with the
provisions set forth in 5 U.S.C. App. 2,
section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6). Grant applications for
the ‘‘AHRQ RFA–HS14–005, Patient
Safety Learning Laboratories: Applying
Design Innovation and Systems
Engineering (P30)’’ are to be reviewed
and discussed at this meeting. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Dated: April 25, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014–10277 Filed 5–5–14; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From
Medical Peer Review Resource, LLC
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of Delisting.
AGENCY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
The Patient Safety and
Quality Improvement Act of 2005, 42
U.S.C. 299b–21 to b-26, (Patient Safety
Act) and the related Patient Safety and
Quality Improvement Final Rule, 42
CFR part 3 (Patient Safety Rule),
published in the Federal Register on
November 21, 2008, 73 FR 70732–
70814, provide for the formation of
Patient Safety Organizations (PSOs),
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of healthcare
delivery. The Patient Safety Rule
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule,
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason, or when a PSO’s listing expires.
AHRQ has accepted a notification of
voluntary relinquishment from Medical
Peer Review Resource, LLC of its status
as a PSO, and has delisted the PSO
accordingly. Medical Peer Review
Resource, LLC submitted this request for
voluntary relinquishment during
revocation proceedings for cause.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on April 2, 2014.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
E:\FR\FM\06MYN1.SGM
06MYN1
Federal Register / Vol. 79, No. 87 / Tuesday, May 6, 2014 / Notices
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from Medical Peer Review Resource,
LLC, PSO number P0026, to voluntarily
relinquish its status as a PSO.
Accordingly, Medical Peer Review
Resource, LLC was delisted effective at
12:00 Midnight ET (2400) on April 2,
2014. Medical Peer Review Resource,
LLC, submitted this request for
voluntary relinquishment during
revocation proceedings for cause.
Medical Peer Review Resource, LLC
has patient safety work product (PSWP)
in its possession. The PSO will meet the
requirements of section 3.108(c)(2)(i) of
the Patient Safety Rule regarding
notification to providers that have
reported to the PSO. In addition,
according to sections 3.108(c)(2)(ii) and
3.108(b)(3) of the Patient Safety Rule
regarding disposition of PSWP, the PSO
has 90 days from the effective date of
delisting and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: April 25, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014–10279 Filed 5–5–14; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sroberts on DSK5SPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 79 FR 21760–21763,
dated April 17, 2014) is amended to
establish the World Trade Center Health
VerDate Mar<15>2010
17:34 May 05, 2014
Jkt 232001
Program, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the title and functional
statement for the Division of
Compensation Analysis and Support
(CCN), National Institute for
Occupational Safety and Health (CC),
insert the following:
World Trade Center Health Program
(CCP). (1) Provides the leadership and
management to comply with the
responsibilities under the James
Zadroga 9/11 Act of 2010; Title) (XXIII
of the Public Health Service Act; (2)
administers the World Trade Center
Health Program (WTCHP); (3) develops,
implements, and maintains a WTCHP
quality assurance program; (4) provides
annual reports to Congress; (5) consults
with stakeholders in carrying out the
WTCHP mission; (6) establishes and
administers a WTCHP Scientific
Technical Advisory Committee; (7)
develops and implements an education
and outreach program; (8) provides for
uniform data collection and for data
integration; (9) provides for
collaboration between Data Centers and
World Trade Center (WTC) Health
Registry; (10) enters into and oversees
contracts for Clinical Centers of
Excellence, Data Centers, and
Nationwide Provider Networks; (11)
enters into agreement with New York
City for purposes of collecting 10% of
the specified funds stated in the
Zadroga 9/11 Act of 2010; (12) ensures
continuity of care; (13) reimburses
Clinical Centers of Excellence for
infrastructure costs; (14) establishes a
process for enrollment of WTC
responders, and Pentagon and
Shanksville responders; (15) conducts
reviews to determine if cancer/types of
cancer should be added to list of WTCrelated health conditions; (16) issues
regulations for medical necessity; (17)
reimburses costs for initial health
evaluation, monitoring, and treatment;
(18) establishes a process to determine
and certify screening-eligible WTC
survivors as certified-eligible survivors;
(19) administers/collects recoupments
from private insurance and workers
compensation; (20) conducts and/or
supports research; (21) ensures that a
Registry of 9/11 victims is maintained;
(22) enters into agreement(s) with the
Centers for Medicare and Medicaid
Services for provider reimbursements;
and (23) ensures compliance with all
Health Insurance Portability and
Accountability Act of 1996 (HIPAA)
Public Law 104–191, statutory and
regulatory provisions that govern the
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
25867
WTCHP as a covered entity, as well as
any HHS HIPAA policies through the
establishment of a WTCHP HIPAA
Compliance Program.
Dated: April 28, 2014.
Sherri A. Berger,
MSPH, Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2014–10179 Filed 5–5–14; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 79 FR 21760–21763,
dated April 17, 2014) is amended to
reflect the reorganization of the Human
Capital and Resource Management
Office, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and the
mission and function statements for the
Human Capital and Resource
Management Office (CAJQ) and insert
the following:
Human Resources Office (CAJQ). (1)
Provides leadership, policy formation,
oversight, guidance, service, and
advisory support and assistance to the
Centers for Disease Control and
Prevention (CDC) and the Agency for
Toxic Substances and Disease Registry
(ATSDR); (2) collaborates as
appropriate, with the CDC Office of the
Director (OD), Centers/Institute/Offices
(CIOs), domestic and international
agencies and organizations; and
provides a focus for short-and long-term
planning within the Human Resource
Office (HRO); (3) develops and
administers human capital and human
resource management policies; (4)
serves as the business steward for all
CDC developed human capital and
human resources management systems
and applications; (5) develops,
maintains, and human resources
management systems and applications;
(5) develops, maintains, and supports
information systems to conduct
E:\FR\FM\06MYN1.SGM
06MYN1
]]>Agencies
[Federal Register Volume 79, Number 87 (Tuesday, May 6, 2014)]
[Notices]
[Pages 25866-25867]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10279]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment From
Medical Peer Review Resource, LLC
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of Delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Act of 2005, 42
U.S.C. 299b-21 to b-26, (Patient Safety Act) and the related Patient
Safety and Quality Improvement Final Rule, 42 CFR part 3 (Patient
Safety Rule), published in the Federal Register on November 21, 2008,
73 FR 70732-70814, provide for the formation of Patient Safety
Organizations (PSOs), which collect, aggregate, and analyze
confidential information regarding the quality and safety of healthcare
delivery. The Patient Safety Rule authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an entity that attests that it meets
the statutory and regulatory requirements for listing. A PSO can be
``delisted'' by the Secretary if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. AHRQ has accepted a
notification of voluntary relinquishment from Medical Peer Review
Resource, LLC of its status as a PSO, and has delisted the PSO
accordingly. Medical Peer Review Resource, LLC submitted this request
for voluntary relinquishment during revocation proceedings for cause.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight ET (2400) on April 2, 2014.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toll free): (866) 403-3697; Telephone (local): (301)
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
Email: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an
[[Page 25867]]
entity that attests that it meets the statutory and regulatory
requirements for listing. A PSO can be ``delisted'' if it is found to
no longer meet the requirements of the Patient Safety Act and Patient
Safety Rule, when a PSO chooses to voluntarily relinquish its status as
a PSO for any reason, or when a PSO's listing expires. Section 3.108(d)
of the Patient Safety Rule requires AHRQ to provide public notice when
it removes an organization from the list of federally approved PSOs.
AHRQ has accepted a notification from Medical Peer Review Resource,
LLC, PSO number P0026, to voluntarily relinquish its status as a PSO.
Accordingly, Medical Peer Review Resource, LLC was delisted effective
at 12:00 Midnight ET (2400) on April 2, 2014. Medical Peer Review
Resource, LLC, submitted this request for voluntary relinquishment
during revocation proceedings for cause.
Medical Peer Review Resource, LLC has patient safety work product
(PSWP) in its possession. The PSO will meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule regarding notification to
providers that have reported to the PSO. In addition, according to
sections 3.108(c)(2)(ii) and 3.108(b)(3) of the Patient Safety Rule
regarding disposition of PSWP, the PSO has 90 days from the effective
date of delisting and revocation to complete the disposition of PSWP
that is currently in the PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: April 25, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014-10279 Filed 5-5-14; 8:45 am]
BILLING CODE 4160-90-P
